Patents Assigned to The Autonomous University of Barcelona
  • Therapeutic use of the encoding sequence of the carboxy-terminal domain of the heavy chain of the tetanus toxin
    Patent number: 8945586
    Abstract: The present invention relates to the therapeutic use of the carboxy-terminal domain of the heavy chain of the tetanus toxin for the treatment of amyotrophic lateral sclerosis (ALS).
    Type: Grant
    Filed: April 5, 2010
    Date of Patent: February 3, 2015
    Assignees: University of Zaragoza, Autonomous University of Barcelona
    Inventors: María Moreno Igoa, Ana Cristina Calvo Royo, Maria Jesús Muñoz Gonzalvo, Maria Pilar Zaragoza Fernández, Rosario Osta Pinzolas, José Aguilera Avila
  • Therapeutic Use of the Encoding Sequence of the Carboxy-Terminal Domain of the Heavy Chain of the Tetanus Toxin
    Publication number: 20100261656
    Abstract: The present invention relates to the therapeutic use of the encoding sequence of the carboxy-terminal domain of the heavy chain of the tetanus toxin and of the polypeptide encoded by said sequence, preferably for the treatment of amyotrophic lateral sclerosis (ALS).
    Type: Application
    Filed: April 5, 2010
    Publication date: October 14, 2010
    Applicants: UNIVERSITY OF ZARAGOZA, AUTONOMOUS UNIVERSITY OF BARCELONA
    Inventors: Maria Moreno Igoa, Ana Cristina Calvo Royo, Maria Jesús Muñoz Gonzalvo, Maria Pilar Zaragoza Fernández, Rosario Osta Pinzolas, José Aguilera Avila
  • Transgenic mouse containing an IGF-1 transgene
    Patent number: 5837875
    Abstract: A transgenic mouse containing an IGF-1 transgene which is operably linked to a promoter sequence and is expressed in the pancreas of the mouse.
    Type: Grant
    Filed: December 26, 1995
    Date of Patent: November 17, 1998
    Assignee: The Autonomous University of Barcelona
    Inventors: Fatima Bosch, Alfons Valera